The year in cardiology 2014: Peripheral circulation

European Heart Journal

Volumn 36, Issue 10, 2015, Pages 591-596

  Aboyans, Victor ^a,b   Brodmann, Marianne ^c   De Carlo, Marco ^d   Clement, Denis ^e   Mazzolai, Lucia ^f   Van Bortel, Lucas ^g   Van Sambeek, Marc R H ^h   Vlachopoulos, Charalambos ⁱ  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE LIMOGES   (France)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g GHENT UNIVERSITY   (Belgium)

^h CATHARINA HOSPITAL   (Netherlands)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ARTERY DISEASE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CAROTID ENDARTERECTOMY; HUMAN; LOWER EXTREMITIES ARTERY DISEASE; META ANALYSIS (TOPIC); MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL CIRCULATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PULSE WAVE; RENAL ARTERY; RENOVASCULAR DISEASE; REVIEW; SYSTEMATIC REVIEW (TOPIC); VEIN THROMBOSIS; AORTIC ANEURYSM, ABDOMINAL; CAROTID ARTERY DISEASES; ENDOVASCULAR SURGERY; KIDNEY ARTERY; KIDNEY DISEASES; LEG; METABOLISM; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT; SYMPATHECTOMY; TRENDS; VASCULARIZATION; VENOUS THROMBOSIS;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ANTICOAGULANTS; AORTIC ANEURYSM, ABDOMINAL; ASPIRIN; BIOMARKERS; CAROTID ARTERY DISEASES; ENDOVASCULAR PROCEDURES; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; KIDNEY DISEASES; LOWER EXTREMITY; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL ARTERY; STENTS; SYMPATHECTOMY; VENOUS THROMBOSIS;

EID: 84924415802     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu515     Document Type: Review

References (47)

1. Jonas DE, Feltner C, Amick HR, Sheridan S, Zheng ZJ, Watford DJ, Carter JL, Rowe CJ, Harris R. Screening for asymptomatic carotid artery stenosis: a systematic review and meta-Analysis for the U.S. Preventive Services Task Force. Ann Intern Med 2014;161:336-346
2. LeFevre ML; U.S. Preventive Services Task Force. Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;161:356-362
3. Kakkos SK, Nicolaides AN, Charalambous I, Thomas D, Giannopoulos A, Naylor AR, Geroulakos G, Abbott AL, Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg 2014;59:956-967
4. Conrad MF, Michalczyk MJ, Opalacz A, Patel VI, LaMuraglia GM, Cambria RP. The natural history of asymptomatic severe carotid artery stenosis. J Vasc Surg 2014; 60:1218-1226
5. Calvet D, Mas JL, Algra A, Becquemin JP, Bonati LH, Dobson J, Fraedrich G, Jansen O, Mali WP, Ringleb PA, Chatellier G, Brown MM, Calvet D, Mas JL, Algra A, Becquemin JP, Bonati LH, Dobson J, Fraedrich G, Jansen O, Mali WP, Ringleb PA, Chatellier G, Brown MM, Algra A, Becquemin JP, Chatellier G, Mas JL, Fraedrich G, Ringleb PA, Jansen O, Brown MM, Carotid Stenting Trialists" Collaboration. Carotid stenting: is there an operator effect?. A pooled analysis from the carotid stenting trialists" collaboration. Stroke 2014;45:527-532
6. McDonald RJ, McDonald JS, Therneau TM, Lanzino G, Kallmes DF, Cloft HJ. Comparative effectiveness of carotid revascularization therapies: evidence from a national hospital discharge database. Stroke 2014;45:3311-3319
7. Lanza G, Setacci C, Cremonesi A, Ricci S, Inzitari D, de Donato G, Castelli P, Pratesi C, Peinetti F, Lanza J, Zaninelli A, Gensini GF. Carotid artery stenting: second consensus document of the ICCS/ISO-SPREAD Joint Committee. Cerebrovasc Dis 2014;38:77-93
8. Brooks WH, Jones MR, Gisler P, McClure RR, Coleman TC, Breathitt L, Spear C. Carotid angioplasty with stenting versus endarterectomy: 10-year randomized trial in a community hospital. JACC Cardiovasc Interv 2014;7:163-168
9. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council onCardiovascularand Stroke Nursing, Councilon Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-2236
10. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2851-2906
11. Zeller T, Baumgartner I, Scheinert D, Brodmann M, Bosiers M, Micari A, Peeters P, Vermassen F, Landini M, Snead DB, Kent KC, Rocha-Singh KJ. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol 2014;64:1568-1576
12. Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M, Tepe G, Naisbitt S, Rosenfield K. The LEVANTI (lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv 2014;7:10-19
13. Nordanstig J, Taft C, Hensäter M, Perlander A, Osterberg K, Jivegård L. Improved quality of life after 1 year with an invasive versus a noninvasive treatment strategy in claudicants: one-year results of the Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Trial. Circulation 2014;130:939-947
14. Tepe G. Randomized Trial of IN.PACTAdmiral(TM) Drug Eluting Balloon vs Standard PTA for the Treatment of SFA and Proximal Popliteal Arterial Disease (INPACT SFA I). In: Presented at Charing Cross International Symposium. April 5, 2014. London, UK.
15. IMPROVE Trial Investigators, Powell JT, Sweeting MJ, Thompson MM, Ashleigh R, Bell R, Gomes M, Greenhalgh RM, Grieve R, Heatley F, Hinchliffe RJ, Thompson SG, Ulug P. Endovascular or open repair strategy for ruptured abdominal aortic aneurysm: 30 day outcomes from IMPROVE randomised trial. BMJ 2014;348: f7661
16. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, DAgostino RB Sr, Dworkin LD; CORAL Investigators. Stenting and medical therapy for atherosclerotic renal-Artery stenosis. N Engl J Med 2014;370:13-22
17. Bhatt DL, Kandzari DE, O"Neill WW, D"Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, SYMPLICITY HTN-3 Investigators.Acontrolled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-1401
18. Riaz IB, Husnain M, Riaz H, Asawaeer M, Bilal J, Pandit A, Shetty R, Lee KS. Meta-Analysis of revascularization versus medical therapy for atherosclerotic renal artery stenosis. Am J Cardiol 2014;114:1116-1123
19. Sampson UKA, Fowkes FGR, McDermott MM, Criqui MH, Aboyans V, Norman PE, Forouzanfar MH, Naghavi M, Song Y, Harrell FE Jr, Denenberg JO, Mensah GA, Ezzati M, Murray C. Global and regional burden of death and disability from peripheral artery disease. Global Heart 2014;9:145-158
20. Nehler MR, Duval S, Diao L, Annex BH, Hiatt WR, Rogers K, Zakharyan A, Hirsch AT. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg 2014;60:686-695
21. de Lemos JA, Kumbhani DJ. Lessons from the heart: troponin elevations in patients with established peripheral artery disease. J Am Coll Cardiol 2014;63:1539-1541
22. Pohlhammer J, Kronenberg F, Rantner B, Stadler M, Peric S, Hammerer-Lercher A, Klein-Weigel P, Fraedrich G, Kollerits B. High-sensitivity cardiac troponin T in patients with intermittent claudication and its relation with cardiovascular events and all-cause mortality - The CAVASIC study. Atherosclerosis 2014;237:711-717
23. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SCJr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL, REACH Registry Investigators. Statin therapyand long-Termadverse limboutcomes inpatientswithperipheral artery disease: insights from the REACH registry. Eur Heart J 2014;35:2864-2872
24. Parmenter BJ, Dieberg G, SmartNA. Exercise training for management of peripheral arterial disease: a systematic review and meta-Analysis. Sports Med 2014 (in press
25. McDermott MM, Guralnik JM, Criqui MH, Ferrucci L, Zhao L, Liu K, Domanchuk K, Spring B, Tian L, Kibbe M, Liao Y, Lloyd Jones D, Rejeski WJ. Home-based walking exercise in peripheral artery disease: 12-month follow-up of the goals randomized trial. J Am Heart Assoc 2014;3:e000711
26. Gardner AW, Parker DE, Montgomery PS, Blevins SM. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc 2014;3:e001107
27. Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, Allmen RS, Vrints CJ; ESC Committee for Practice Guidelines (CPG), Document Reviewers; Authors/Task Force Members. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873-2926
28. Aboyans V, Bataille V, Bliscaux P, Ederhy S, Filliol D, Honton B, Kurtz B, Messas E, Mohty D, Brochet E, Kownator S; investigators of the E2T3A study. Effectiveness of screening for abdominal aortic aneurysm during echocardiography. Am J Cardiol 2014;114:1100-1104
29. de Bruin JL, Baas AF, Heymans MW, Buimer MG, Prinssen M, Grobbee DE, Blankensteijn JD; DREAM Study Group. Statin therapy is associated with improved survival after endovascular and open aneurysm repair. J Vasc Surg 2014;59:39-44
30. Galiñanes EL, Reynolds S, Dombrovskiy VY, Vogel TR. The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes. Vascular 2014. (online
31. De Rango P, Verzini F, Parlani G, Cieri E, Simonte G, Farchioni L, Isernia G, Cao P. Safety of chronic anticoagulation therapy after endovascular abdominal aneurysm repair (EVAR). Eur J Vasc Endovasc Surg 2014;47:296-303
32. Lazarides MK, Georgiadis GS, Charalampidis DG, Antoniou GA, Georgakarakos EI, Trellopoulos G. Impact of long-Term warfarin treatment on EVAR durability: a meta-Analysis. J Endovasc Ther 2014;21:148-153
33. Malas M, Arhuidese I, Qazi U, Black J, Perler B, Freischlag JA. Perioperative mortality following repair of abdominal aortic aneurysms: application of a randomized clinical trial to real-world practice using a validated nationwide data set. JAMA Surg 2014;149: 1260-1265
34. Raux M, Patel VI, Cochennec F, Mukhopadhyay S, Desgranges P, Cambria RP, Becquemin JP, LaMuraglia GM. A propensity-matched comparison of outcomes for fenestrated endovascular aneurysm repair and open surgical repair of complex abdominal aortic aneurysms. J Vasc Surg 2014;60:858-863
35. Scali ST, Feezor RJ, Chang CK, Waterman AL, Berceli SA, Huber TS, Beck AW. Critical analysis of results after chimneyendovascular aortic aneurysm repair raises cause for concern. J Vasc Surg 2014;60:865-873
36. van Beek SC, Conijn AP, Koelemay MJ, Balm R. Editor"s Choice - endovascular aneurysm repair versus open repair for patients with a ruptured abdominal aortic aneurysm: a systematic review and meta-Analysis of short-Term survival. Eur J Vasc Endovasc Surg 2014;47:593-602
37. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell GF, Najjar SS, Newman AB, Ohishi M, Pannier B, Pereira T, Vasan RS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Willum Hansen T, Zoungas S, McEniery CM, Cockcroft JR, Wilkinson IB. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-Analysis of prospective observational data from 17, 635 subjects. J Am Coll Cardiol 2014;63:636-646
38. Vlachopoulos C, Ioakeimidis N, Aznaouridis K, Terentes-Printzios D, Rokkas K, Aggelis A, Panagiotakos D, Stefanadis C. Prediction of cardiovascular events with aortic stiffness in patients with erectile dysfunction. Hypertension 2014;64: 672-678
39. Bots ML, Groenewegen KA, Anderson TJ, Britton AR, Dekker JM, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Ikram MA, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O'Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Franco OH, Peters SA, den Ruijter HM. Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration. Hypertension 2014;63: 1173-1181
40. van Sloten TT, Schram MT, van den Hurk K, Dekker JM, Nijpels G, Henry RM, Stehouwer CD. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 2014;63:1739-1747
41. Herbert A, Cruickshank JK, Laurent S, Boutouyrie P; on behalf of The Reference Values for Arterial Measurements Collaboration, on behalf of The Reference Values for Arterial Measurements Collaboration. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J 2014;35:3122-3133
42. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost 2014;12:1580-1590
43. Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA; INSPIRE Study Investigators. Aspirin for the prevention of recurrent venous thromboembolism: The INSPIRE Collaboration. Circulation 2014;130: 1062-1071
44. Baber U, Mastoris I, Mehran R. Balancing ischaemia and bleeding risks with novel oral anticoagulants. Nat Rev Cardiol 2014;11:693-703
45. Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 2014;124:196-203
46. Napolitano M, Saccullo G, Malato A, Sprini D, Ageno W, Imberti D, Mascheroni D, Bucherini E, Gallucci P, D'Alessio A, Prantera T, Spadaro P, Rotondo S, Di Micco P, Oriana V, Urbano O, Recchia F, Ghirarduzzi A, Lo Coco L, Mancuso S, Casuccio A, Rini GB, Siragusa S. Optimal duration of low molecular weight heparin for the treatment of cancer-related deep vein thrombosis: the Cancer-DACUSStudy. J Clin Oncol 2014;32:3607-3612
47. Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2014;1:CD002783